Today: 17 May 2026
Browse Category

Technology 15 May 2026 - 17 May 2026

Zeta Global Stock Rises as Snowflake Deal Comes Ahead of Key Vote

Zeta Global Stock Rises as Snowflake Deal Comes Ahead of Key Vote

Zeta Global shares closed at $17.19, up 3.68% Friday, outperforming major indexes after joining Snowflake’s Open Semantic Interchange data initiative. The stock retreated to $17.14 after hours. Zeta will present at the JPM 2026 Global Technology, Media and Communications Conference on Monday. First-quarter revenue jumped 50% to $396 million, prompting a full-year guidance raise.
Alphabet Stock Faces $4.8 Trillion Pressure After Ackman Exit, AI Bonds, Google I/O

Alphabet Stock Faces $4.8 Trillion Pressure After Ackman Exit, AI Bonds, Google I/O

Alphabet shares closed at $396.78 Friday, down 1.07% after Pershing Square, led by Bill Ackman, fully exited its stake to fund a new Microsoft position. Alphabet also raised $3.6 billion in its first yen bond sale, the largest by a foreign company. First-quarter revenue rose 22% to $109.9 billion, with Google Cloud revenue up 63% to $20 billion.
Atlassian Shares Jump 8% on Friday, Eyes on Monday for AI Interest

Atlassian Shares Jump 8% on Friday, Eyes on Monday for AI Interest

Atlassian shares jumped 8.16% to $87.46 Friday but ended the week down 4.5%. Truist Securities reiterated a Buy rating and $100 target after the Team 26 event, citing AI monetization as a key issue. Nasdaq regular trading resumes Monday. Atlassian last posted a fiscal Q3 revenue gain of 32% year-over-year to $1.787 billion but reported a GAAP operating loss of $56.3 million.
SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

SpaceX plans to list on Nasdaq as early as June 12 under the ticker SPCX, seeking to raise about $75 billion at a $1.75 trillion valuation, sources told Reuters. The company aims to publish its prospectus next week, with investor meetings set for June 4. Bloomberg reported Brookfield has already placed a $2 billion bet ahead of the IPO. SpaceX’s filing includes supervoting shares and strict limits on shareholder proposals.
AT&T, Verizon, T-Mobile Rally Against Dead Zones With Uncommon Satellite Move, Eye Starlink Push

AT&T, Verizon, T-Mobile Rally Against Dead Zones With Uncommon Satellite Move, Eye Starlink Push

AT&T, Verizon, and T-Mobile announced plans to jointly build a satellite-based network to eliminate U.S. wireless dead zones, aiming to connect ordinary phones directly to satellites. The move follows the FCC’s approval of EchoStar’s $40 billion spectrum sale to SpaceX and AT&T. The carriers have an agreement in principle but have not finalized terms. AT&T reported $31.5 billion in Q1 revenue and $126.4 billion in net debt.
Ondas Stock Faces a $390 Million Test After Drone-Revenue Surge

Ondas Stock Faces a $390 Million Test After Drone-Revenue Surge

Ondas raised its 2026 revenue target to at least $390 million after first-quarter revenue jumped to $50.1 million from $4.3 million a year earlier. Shares traded near $11.20 Friday after a 27% gain Thursday. The company posted a $42.7 million operating loss and widened its adjusted EBITDA loss to $10.9 million. Backlog rose to $457 million, up from $68.3 million at the end of 2025.
15 May 2026
Why Cerebras Stock Is Down Today: Wall Street Hits the Brakes After a Blowout AI IPO

Why Cerebras Stock Is Down Today: Wall Street Hits the Brakes After a Blowout AI IPO

Cerebras Systems shares fell about 4% to $298 in early Friday trading, retreating from Thursday’s $311.07 close after a 68% Nasdaq debut. The stock remained roughly 61% above its $185 IPO price. Investors cited concerns over high valuation, customer concentration, and how much OpenAI demand is already priced in. Cerebras raised $5.55 billion in its offering, which was expected to close Friday.
Pershing Square Inc. Bets on Microsoft as Ackman Sees an AI Bargain

Pershing Square Inc. Bets on Microsoft as Ackman Sees an AI Bargain

Bill Ackman said Friday that Pershing Square has built a new position in Microsoft, citing the stock’s “highly compelling” valuation. The disclosure follows Pershing Square’s $5 billion IPO and private placement last month. Ackman began buying Microsoft in February after a drop tied to slower cloud growth and heavy AI spending. Microsoft shares traded at $409.43, up 1% premarket.
Ackman’s Microsoft Bet Puts $190 Billion AI Spending Plan Back in Wall Street’s Crosshairs

Ackman’s Microsoft Bet Puts $190 Billion AI Spending Plan Back in Wall Street’s Crosshairs

Pershing Square will disclose a new stake in Microsoft in a 13F filing Friday, according to Bill Ackman. Microsoft shares have dropped about 15% this year amid concerns over AI spending and slower cloud growth. The company reported $82.9 billion in revenue and $31.8 billion in net income last quarter, but plans to invest around $190 billion in capital expenditures in 2026.
Figma Stock Jumps 10% Premarket After AI Tools Lift 2026 Revenue Forecast

Figma Stock Jumps 10% Premarket After AI Tools Lift 2026 Revenue Forecast

Figma raised its 2026 revenue forecast to $1.422 billion–$1.428 billion after first-quarter revenue jumped 46% to $333.4 million. Shares climbed 10.6% in premarket trading to $22.39. Paid customers rose 54% to about 690,000, with strong adoption of AI-linked products and new charges for AI credits. Figma began enforcing AI credit limits in March; over 75% of affected enterprise users kept using the service.
Dow Back Above 50,000 as Nvidia, Cisco AI Rally Faces Friday Yield Shock

Dow Back Above 50,000 as Nvidia, Cisco AI Rally Faces Friday Yield Shock

U.S. stock futures dropped early Friday, with Dow E-minis down 0.66%, S&P 500 E-minis off 1.07%, and Nasdaq 100 E-minis falling 1.56% after record closes. Cisco shares jumped 13.4% Thursday on strong earnings and a raised revenue forecast. The 10-year Treasury yield reached 4.54%, and Brent crude climbed to $109 a barrel as the Strait of Hormuz stayed closed. Investors await Nvidia and retailer earnings next week.
Mobix Labs Stock Soars 79% After Rare-Earth Deal Plan — Why MOBX Is Suddenly in the China Supply-Chain Fight

Mobix Labs Stock Soars 79% After Rare-Earth Deal Plan — Why MOBX Is Suddenly in the China Supply-Chain Fight

Mobix Labs shares jumped 78.74% to $3.11 Thursday after it signed a non-binding letter of intent to acquire Special Project Delivery, a U.S. critical-minerals and energy-storage platform. The company also amended a convertible note with Leviston Resources, raising principal to $4 million for $833,000 in new cash. SPD was formed in 2019 and is based in Newport Beach, California.
1 2 3 217

Stock Market Today

  • Dow Appoints Karen S. Carter as First Female CEO; Jim Fitterling to Executive Chair
    May 16, 2026, 9:16 PM EDT. Dow (NYSE: DOW) named Karen S. Carter as CEO, effective July 1, 2026, marking a historic first female leader in its 126-year existence. Carter, 55, promoted from Chief Operating Officer, has over 30 years with the company, overseeing key segments including Packaging and Specialty Plastics. Jim Fitterling, current CEO and Chairman, will shift to Executive Chairman, focusing on strategy and governance. The move concludes a multi-year succession plan by Dow's board. Carter's appointment signals confidence in internal operational leadership rather than an external transformation figure. The transition aims to sustain momentum amid ongoing challenges in global chemical and materials markets, maintaining strategic continuity with Independent Lead Director Richard Davis supporting governance.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Go toTop